Summary:
A Multicenter, Randomized, Double-blind, Placebo-controlled study of the safety and efficacy of TS-121 (study drug) as an adjunctive (additional) treatment for patients with Major Depressive Disorder with an inadequate response to current antidepressant treatment.
Study is about 3 months long with 7 visits (as well as additional visit to ophthalmologist)
If qualified, you will be treated by a board-certified psychiatrist with NO charge to your insurance and you can earn $$$ for participating!
Qualified Participants Must:
• Have diagnosis of Major Depressive Disorder
•
Be age 18-65
•
Be on a current antidepressant for at least 4 weeks at current dose
•
Not have any of the following diagnosis: psychosis, schizophrenia, bipolar, OCD, PTSD, Alzheimer's, Parkinson's, Multiple Sclerosis, Huntington's disease, epilepsy, hepatitis or HIV
•
No drug or alcohol abuse within last 12 months
•
No suicide attempt within last 6 months
•
No benzodiazepines or amphetamines
Qualified Participants May Receive:
$40-$80 for each completed visit if patient qualifies